Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014 (2014), Article ID 973139, 8 pages
http://dx.doi.org/10.1155/2014/973139
Research Article

Evidences of +896 A/G TLR4 Polymorphism as an Indicative of Prevalence of Complications in T2DM Patients

1Department of Pathobiology and Medical and Forensic Biotechnologies, University of Palermo, Tukory’s Street 211, 90134 Palermo, Italy
2Metabolic Diseases and Diabetology Unit, Italian National Research Center on Aging (INRCA), Ancona, Italy
3Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Italy
4Center of Clinical Pathology and Innovative Therapy, Italian National Research Center on Aging (INRCA), Ancona, Italy
5Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
6Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain
7Department of Cardiovascular and Metabolic Diseases, IRCCS Gruppo Multimedica, Sesto San Giovanni (MI), Italy
8Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, CNR-ISOF and IRCCS Neuroscience, Bologna, Italy
9Biostatistical Center, Italian National Research Center on Aging (INRCA), Ancona, Italy
10Experimental Models in Clinical Pathology, Italian National Research Center on Aging (INRCA), Ancona, Italy

Received 23 January 2014; Accepted 6 March 2014; Published 2 April 2014

Academic Editor: José Cesar Rosa

Copyright © 2014 Carmela Rita Balistreri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “International diabetes federation,” in Updated Diabetes Atlas, N. Unwin, D. Whiting, L. Guariguata, G. Ghyoot, and D. Gan, Eds., Brussels, Belgium, 5th edition, 2011.
  2. C. R. Balistreri, C. Caruso, and G. Candore, “The role of adipose tissue and adipokines in obesity-related inflammatory diseases,” Mediators of Inflammation, vol. 2010, Article ID 802078, 19 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. G. S. Hotamisligil, “Inflammation and metabolic disorders,” Nature, vol. 444, no. 7121, pp. 860–867, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Lontchi-Yimagou, E. Sobngwi, T. E. Matsha, and A. P. Kengne, “Diabetes mellitus and inflammation,” Current Diabetes Report, vol. 13, pp. 435–444, 2013. View at Google Scholar
  5. H. Kolb and T. Mandrup-Poulsen, “An immune origin of type 2 diabetes?” Diabetologia, vol. 48, no. 6, pp. 1038–1050, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. S. E. Shoelson, J. Lee, and A. B. Goldfine, “Inflammation and insulin resistance,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 1793–1801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Okada, W. L. Chong, J. Hu et al., “Insulin receptors in β-cells are critical for islet compensatory growth response to insulin resistance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 21, pp. 8977–8982, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. Q. Wang and T. Jin, “The role of insulin signaling in the development of β-cell dysfunction and diabetes,” Islets, vol. 1, no. 2, pp. 95–101, 2009. View at Google Scholar · View at Scopus
  9. C. R. Balistreri, G. Colonna-Romano, D. Lio, G. Candore, and C. Caruso, “TLR4 polymorphisms and ageing: implications for the pathophysiology of age-related diseases,” Journal of Clinical Immunology, vol. 29, no. 4, pp. 406–415, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Sirisinha, “Insight into the mechanisms regulating immunehomeostasis in health and disease,” Asian Pacific Journal of Allergy and Immunology, vol. 29, no. 1, pp. 1–14, 2011. View at Google Scholar · View at Scopus
  11. K. Newton and V. M. Dixit, “Signaling in innate immunity and inflammation,” Cold Spring Harbor Perspectives in Biology, vol. 4, no. 3, Article ID 006049, 2012. View at Publisher · View at Google Scholar
  12. M. J. Hutton, G. Soukhatcheva, J. D. Johnson, and C. B. Verchere, “Role of the TLR signalling molecule TRIF in beta-cell function and glucose homeostasis,” Islets, vol. 2, no. 2, pp. 104–111, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. H. M. Garay-Malpartida, R. F. Mourão, M. Mantovani, I. A. Santos, M. C. Sogayar, and A. C. Goldberg, “Toll-like receptor 4 (TLR4) expression in human and murine pancreatic beta-cells affects cell viability and insulin homeostasis,” BMC Immunology, vol. 12, article 18, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Ellingsgaard, I. Hauselmann, B. Schuler et al., “Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells,” Nature Medicine, vol. 17, no. 11, pp. 1481–1489, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Amyot, M. Semache, M. Ferdaoussi, G. Fontés, and V. Poitout, “Lipopolysaccharides impair insulin gene expression in isolated islets of langerhans via toll-like receptor-4 and nf-κb signalling,” PLoS ONE, vol. 7, no. 4, Article ID e36200, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Shi, M. V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J. S. Flier, “TLR4 links innate immunity and fatty acid-induced insulin resistance,” Journal of Clinical Investigation, vol. 116, no. 11, pp. 3015–3025, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. D. M. L. Tsukumo, M. A. Carvalho-Filho, J. B. C. Carvalheira et al., “Loss-of-function mutation in toll-like receptor 4 prevents diet-induced obesity and insulin resistance,” Diabetes, vol. 56, no. 8, pp. 1986–1998, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Suganami, T. Mieda, M. Itoh, Y. Shimoda, Y. Kamei, and Y. Ogawa, “Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation,” Biochemical and Biophysical Research Communications, vol. 354, no. 1, pp. 45–49, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. C. R. Balistreri, C. Caruso, F. Listì, G. Colonna-Romano, D. Lio, and G. Candore, “LPS-mediated production of pro/anti-inflammatory cytokines and eicosanoids in whole blood samples: biological effects of +896A/G TLR4 polymorphism in a Sicilian population of healthy subjects,” Mechanisms of Ageing and Development, vol. 132, no. 3, pp. 86–92, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. F. S. Belforte, F. Coluccio Leskow, E. Poskus, and A. Penas Steinhardt, “Toll-like receptor 4 D299G polymorphism in metabolic disorders: a meta-analysis,” Molecular Biology Reports, vol. 40, pp. 3015–3020, 2013. View at Google Scholar
  21. M. Buraczynska, I. Baranowicz-Gaszczyk, J. Tarach, and A. Ksiazek, “Toll-like receptor 4 gene polymorphism and early onset of diabetic retinopathy in patients with type 2 diabetes,” Human Immunology, vol. 70, no. 2, pp. 121–124, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Lirussi, “The global challenge of type 2 diabetes and the strategies for response in ethnic minority groups,” Diabetes/Metabolism Research and Reviews, vol. 26, no. 6, pp. 421–432, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. P. W. F. Wilson, J. B. Meigs, L. Sullivan, C. S. Fox, D. M. Nathan, and R. B. D'Agostino Sr., “Prediction of incident diabetes mellitus in middle-aged adults: the framingham offspring study,” Archives of Internal Medicine, vol. 167, no. 10, pp. 1068–1074, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. P. J. Talmud, A. D. Hingorani, J. A. Cooper et al., “Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: whitehall II prospective cohort study,” British Medical Journal, vol. 340, Article ID b4838, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. M. J. Kolek, J. F. Carlquist, J. B. Muhlestein et al., “Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes,” American Heart Journal, vol. 148, no. 6, pp. 1034–1040, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Rudofsky Jr., P. Reismann, S. Witte et al., “Asp299Gly and Thr399Ile genotypes of the TLR4 Gene are associated with a reduced prevalence of diabetic neuropathy in patients with Type 2 diabetes,” Diabetes Care, vol. 27, no. 1, pp. 179–183, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Liu, W. Lu, Q. Qian, W. Qi, J. Hu, and B. Feng, “Frequency of TLR 2, 4, and 9 gene polymorphisms in Chinese population and their susceptibility to type 2 diabetes and coronary artery disease,” Journal of Biomedice and Biotechnology, vol. 2012, Article ID 373945, 7 pages, 2012. View at Publisher · View at Google Scholar
  28. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 30, pp. S42–S47, 2007. View at Google Scholar
  29. D. W. Cockcroft and M. H. Gault, “Prediction of creatinine clearance from serum creatinine,” Nephron, vol. 16, no. 1, pp. 31–41, 1976. View at Google Scholar · View at Scopus
  30. D. R. Matthews, J. P. Hosker, and A. S. Rudenski, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Google Scholar · View at Scopus
  31. C. R. Balistreri, M. P. Grimaldi, M. Chiappelli et al., “Association between the polymorphisms of TLR4 and CD14 genes and Alzheimer's disease,” Current Pharmaceutical Design, vol. 14, no. 26, pp. 2672–2677, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. M. R. Dasu, S. Devaraj, L. Zhao, D. H. Hwang, and I. Jialal, “High glucose induces toll-like receptor expression in human monocytes Mechanism of activation,” Diabetes, vol. 57, no. 11, pp. 3090–3098, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. M. R. Dasu and I. Jialal, “Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors,” American Journal of Physiology—Endocrinology and Metabolism, vol. 300, no. 1, pp. E145–E154, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. M. R. Dasu, S. Ramirez, and R. R. Isseroff, “Toll-like receptors and diabetes: a therapeutic perspective,” Clinical Science, vol. 122, no. 5, pp. 203–214, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. J. J. Kim and D. D. Sears, “TLR4 and insulin resistance,” Gastroenterology Research and Practice, vol. 2010, Article ID 212563, 11 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Ladefoged, K. Buschard, and A. M. Hansen, “Increased expression of toll-like receptor 4 and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetes,” Acta Pathologica, Microbiologica, et Immunologica Scandinavica, vol. 121, pp. 531–538, 2013. View at Google Scholar
  37. M. E. Stegenga, S. N. van der Crabben, R. M. E. Blümer et al., “Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia,” Blood, vol. 112, no. 1, pp. 82–89, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. M.-N. Peraldi, J. Berrou, N. Dulphy et al., “Oxidative stress mediates a reduced expression of the activating receptor NKG2D in NK cells from end-stage renal disease patients,” Journal of Immunology, vol. 182, no. 3, pp. 1696–1705, 2009. View at Google Scholar · View at Scopus
  39. K. Zhang and R. J. Kaufman, “From endoplasmic-reticulum stress to the inflammatory response,” Nature, vol. 454, no. 7203, pp. 455–462, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Berrou, S. Fougeray, and M. Venot, “Natural killer cell function, an important target for infection and tumor protection, is impaired in type 2 diabetes,” PLoS ONE, vol. 8, Article ID e62418, 2013. View at Google Scholar
  41. L. M. A. J. Muller, K. J. Gorter, E. Hak et al., “Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus,” Clinical Infectious Diseases, vol. 41, no. 3, pp. 281–288, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. E. Lontchi-Yimagou, E. Sobngwi, T. E. Matsha, and A. P. Kengne, “Diabetes mellitus and inflammation,” Current Diabetes Reports, vol. 13, pp. 435–444, 2013. View at Google Scholar
  43. P. Dandona, H. Ghanim, A. Bandyopadhyay et al., “Insulin suppresses endotoxin-induced oxidative, nitrosative, and inflammatory stress in humans,” Diabetes Care, vol. 33, no. 11, pp. 2416–2423, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Dandona, A. Chaudhuri, H. Ghanim, and P. Mohanty, “Insulin as an anti-inflammatory and antiatherogenic modulator,” Journal of the American College of Cardiology, vol. 53, no. 5, pp. S14–S20, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. E. Esteve, W. Ricart, and J.-M. Fernández-Real, “Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 14, no. 5, pp. 483–490, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Erridge, “Diet, commensals and the intestine as sources of pathogen-associated molecular patterns in atherosclerosis, type 2 diabetes and non-alcoholic fatty liver disease,” Atherosclerosis, vol. 216, no. 1, pp. 1–6, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Rosa Ramirez and M. Ravi Krishna Dasu “, “Toll-like receptors and diabetes complications: recent advances,” Current Diabetes Review, vol. 8, pp. 480–488, 2012. View at Google Scholar
  48. C. R. Balistreri, G. Candore, G. Accardi et al., “Genetics of longevity. Data from the studies on Sicilian centenarians,” Immunity & Ageing, vol. 9, article 8, 2012. View at Publisher · View at Google Scholar · View at Scopus